当前位置:首页 - 行情中心 - 梅花生物(600873) - 财务分析 - 现金流量表

梅花生物

(600873)

  

流通市值:201.63亿  总市值:201.63亿
流通股本:28.04亿   总股本:28.04亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金19,693,909,055.0313,052,263,813.386,535,506,477.8526,284,830,929.52
  收到的税费返还485,962,245.29297,353,645.61148,716,993.34564,637,199.44
  收到其他与经营活动有关的现金225,492,253.75152,411,464.5535,537,858.65314,266,906.41
  经营活动现金流入小计20,405,363,554.0713,502,028,923.546,719,761,329.8427,163,735,035.37
  购买商品、接受劳务支付的现金15,143,363,786.9311,282,077,575.216,918,296,320.5619,183,664,918.44
  支付给职工以及为职工支付的现金1,478,100,749.421,036,586,807.14506,769,238.421,888,800,255.38
  支付的各项税费470,037,077.77313,267,323.28122,889,775.631,064,967,949.58
  支付其他与经营活动有关的现金682,565,765.46480,957,133.89327,363,483.781,017,042,265.74
  经营活动现金流出小计17,774,067,379.5813,112,888,839.527,875,318,818.3923,154,475,389.14
  经营活动产生的现金流量净额2,631,296,174.49389,140,084.02-1,155,557,488.554,009,259,646.23
二、投资活动产生的现金流量:
  收回投资收到的现金69,995,988.8583,631,190.33240,191,771.749,416,904.11
  取得投资收益收到的现金52,125,800.4729,819,638.7416,232,473.0889,022,905.51
  处置固定资产、无形资产和其他长期资产收回的现金净额14,808,920.0111,498,534.54927,536.213,929,974.23
  处置子公司及其他营业单位收到的现金净额322,188,026.4322,188,026.4--
  投资活动现金流入小计459,118,735.73447,137,390.01257,351,780.99142,369,783.85
  购建固定资产、无形资产和其他长期资产支付的现金1,748,724,174.481,134,643,863.42522,609,583.682,085,097,608.71
  投资支付的现金2,009,128,995.871,084,758,939.83261,022,618.051,021,970,127.42
  取得子公司及其他营业单位支付的现金---154,418,006.87
  支付其他与投资活动有关的现金3,098,394.32,883,915.81624,339.925,064,758.89
  投资活动现金流出小计3,760,951,564.652,222,286,719.06784,256,541.633,286,550,501.89
  投资活动产生的现金流量净额-3,301,832,828.92-1,775,149,329.05-526,904,760.64-3,144,180,718.04
三、筹资活动产生的现金流量:
  取得借款收到的现金3,393,273,632.271,983,278,909.211,040,647,9955,303,483,203.63
  收到其他与筹资活动有关的现金467,728,165.98277,489,110.71216,991,590.33631,857,578.29
  筹资活动现金流入小计3,861,001,798.252,260,768,019.921,257,639,585.335,935,340,781.92
  偿还债务支付的现金3,295,656,521.071,876,810,000.01957,100,0005,009,880,000.02
  分配股利、利润或偿付利息支付的现金1,238,201,512.7525,564,775.5313,136,936.451,255,746,825.79
  支付其他与筹资活动有关的现金422,709,409.19335,766,648.9190,391,605.65677,245,874.35
  筹资活动现金流出小计4,956,567,443.012,238,141,424.441,160,628,542.16,942,872,700.16
  筹资活动产生的现金流量净额-1,095,565,644.7622,626,595.4897,011,043.23-1,007,531,918.24
四、汇率变动对现金及现金等价物的影响-85,236,013.23-61,143,692.42-31,457,118.4317,029,234.7
五、现金及现金等价物净增加额-1,851,338,312.42-1,424,526,341.97-1,616,908,324.39-125,423,755.35
  加:期初现金及现金等价物余额4,006,435,846.794,006,435,846.794,006,435,846.794,131,859,602.14
  期末现金及现金等价物余额2,155,097,534.372,581,909,504.822,389,527,522.44,006,435,846.79
补充资料:
  净利润-661,862,706.23-3,280,879,912.1
  资产减值准备-29,797,994.41-36,034,934.84
  固定资产和投资性房地产折旧-744,691,655.08-1,352,389,043.85
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-744,691,655.08-1,352,389,043.85
  无形资产摊销-25,891,648.42-49,442,167.88
  长期待摊费用摊销-22,078,508.3-41,023,855.2
  处置固定资产、无形资产和其他长期资产的损失--10,663,776.45--834,727.21
  固定资产报废损失-6,456,826.23-37,764,435.04
  公允价值变动损失--21,336,805.37--32,838,480.38
  财务费用-65,139,732.01-19,056,345.85
  投资损失--57,912,082.18--57,847,648.05
  递延所得税-624,227--4,837,561.2
  其中:递延所得税资产减少-624,227-16,747,667.25
    递延所得税负债增加----21,585,228.45
  存货的减少--1,047,278,926.63-32,921,201.66
  经营性应收项目的减少--216,263,282.68-291,262,779.09
  经营性应付项目的增加-180,347,214.46--197,284,586.92
  其他----831,441,015.05
  现金的期末余额-2,581,909,504.82-4,006,435,846.79
  减:现金的期初余额-4,006,435,846.79-4,131,859,602.14
  现金及现金等价物的净增加额--1,424,526,341.97--125,423,755.35
公告日期2026-10-312026-08-152026-04-222026-04-22
审计意见(境内)标准无保留意见
TOP↑